| Protein | Potency Measurements | Inhibition Measurements | Activation Measurements | Drugs |
|---|
| Chain A, Ferritin light chain | 4 | 0 | 0 | 4 |
| thioredoxin reductase | 10 | 0 | 0 | 10 |
| TDP1 protein | 16 | 0 | 0 | 16 |
| Microtubule-associated protein tau | 6 | 0 | 0 | 6 |
| Smad3 | 4 | 0 | 0 | 4 |
| aldehyde dehydrogenase 1 family, member A1 | 11 | 0 | 0 | 11 |
| alpha-galactosidase | 1 | 0 | 0 | 1 |
| 15-hydroxyprostaglandin dehydrogenase [NAD(+)] isoform 1 | 3 | 0 | 0 | 3 |
| flap endonuclease 1 | 5 | 0 | 0 | 5 |
| DNA polymerase iota isoform a (long) | 5 | 0 | 0 | 5 |
| DNA topoisomerase 2-alpha | 0 | 0 | 0 | 1 |
| Acetylcholinesterase | 0 | 1 | 0 | 1 |
| Chain E, Purine nucleoside phosphorylase | 0 | 1 | 0 | 1 |
| Chain A, HADH2 protein | 4 | 0 | 0 | 4 |
| Chain B, HADH2 protein | 4 | 0 | 0 | 4 |
| Chain A, ATP-DEPENDENT DNA HELICASE Q1 | 3 | 0 | 0 | 3 |
| Thymidine kinase | 0 | 2 | 0 | 2 |
| phosphopantetheinyl transferase | 3 | 0 | 0 | 3 |
| GLS protein | 6 | 0 | 0 | 6 |
| thyroid stimulating hormone receptor | 5 | 0 | 0 | 5 |
| EWS/FLI fusion protein | 7 | 0 | 0 | 7 |
| arylsulfatase A | 6 | 0 | 0 | 6 |
| euchromatic histone-lysine N-methyltransferase 2 | 14 | 0 | 0 | 14 |
| activating transcription factor 6 | 3 | 0 | 0 | 3 |
| Histone H2A.x | 7 | 0 | 0 | 7 |
| Bloom syndrome protein isoform 1 | 7 | 0 | 0 | 7 |
| hemoglobin subunit beta | 1 | 0 | 0 | 1 |
| atrial natriuretic peptide receptor 1 precursor | 2 | 0 | 0 | 2 |
| ubiquitin carboxyl-terminal hydrolase 2 isoform a | 3 | 0 | 0 | 3 |
| lamin isoform A-delta10 | 10 | 0 | 0 | 10 |
| Solute carrier family 22 member 1 | 0 | 1 | 0 | 3 |
| ATP-binding cassette sub-family C member 3 | 0 | 12 | 0 | 12 |
| Multidrug resistance-associated protein 4 | 0 | 12 | 0 | 12 |
| Solute carrier family 22 member 6 | 0 | 1 | 0 | 2 |
| Bile salt export pump | 0 | 4 | 0 | 4 |
| Bile salt export pump | 0 | 15 | 0 | 15 |
| Purine nucleoside phosphorylase | 0 | 1 | 0 | 1 |
| Thymidine kinase, cytosolic | 0 | 1 | 0 | 2 |
| POU domain, class 2, transcription factor 2 | 0 | 0 | 0 | 2 |
| Cytochrome P450 2C9 | 0 | 6 | 0 | 6 |
| Cytochrome P450 2J2 | 0 | 5 | 0 | 5 |
| Disintegrin and metalloproteinase domain-containing protein 17 | 2 | 0 | 0 | 2 |
| Purine nucleoside phosphorylase | 0 | 0 | 3 | 3 |
| Solute carrier family 22 member 6 | 0 | 0 | 0 | 2 |
| Thymidine kinase | 0 | 1 | 0 | 1 |
| Solute carrier family 22 member 8 | 0 | 0 | 0 | 1 |
| Canalicular multispecific organic anion transporter 1 | 0 | 11 | 0 | 11 |
| Thymidine kinase | 0 | 2 | 0 | 2 |
| Chain A, MAJOR APURINIC/APYRIMIDINIC ENDONUCLEASE | 8 | 0 | 0 | 8 |
| Chain A, MTA/SAH nucleosidase | 0 | 1 | 0 | 1 |
| Chain A, Ribosome-inactivating protein alpha-trichosanthin | 0 | 0 | 1 | 1 |
| Chain A, Ricin A chain | 0 | 0 | 1 | 1 |
| Chain A, Ribosome-inactivating protein 3 | 0 | 0 | 1 | 1 |
| Chain A, Phenylethanolamine N-methyltransferase | 0 | 0 | 1 | 1 |
| Chain A, Phenylethanolamine N-methyltransferase | 0 | 0 | 1 | 1 |
| Chain A, Phenylethanolamine N-methyltransferase | 0 | 0 | 1 | 1 |
| Chain A, Phenylethanolamine N-methyltransferase | 0 | 0 | 1 | 1 |
| Chain A, Phenylethanolamine N-methyltransferase | 0 | 0 | 1 | 1 |
| Chain A, Phenylethanolamine N-methyltransferase | 0 | 0 | 1 | 1 |
| Chain A, Phenylethanolamine N-methyltransferase | 0 | 0 | 1 | 1 |
| Chain A, Phenylethanolamine N-methyltransferase | 0 | 0 | 1 | 1 |
| Chain A, Phenylethanolamine N-methyltransferase | 0 | 0 | 1 | 1 |
| Chain A, Phenylethanolamine N-methyltransferase | 0 | 0 | 1 | 1 |
| Chain A, Phenylethanolamine N-methyltransferase | 0 | 0 | 1 | 1 |
| Chain A, Phenylethanolamine N-methyltransferase | 0 | 0 | 1 | 1 |
| Chain A, Phenylethanolamine N-methyltransferase | 0 | 0 | 1 | 1 |
| RAR-related orphan receptor gamma | 11 | 0 | 0 | 11 |
| AR protein | 15 | 0 | 0 | 15 |
| nuclear receptor subfamily 1, group I, member 3 | 10 | 0 | 0 | 10 |
| cytochrome P450 family 3 subfamily A polypeptide 4 | 7 | 0 | 0 | 7 |
| glucocorticoid receptor [Homo sapiens] | 11 | 0 | 0 | 11 |
| estrogen-related nuclear receptor alpha | 15 | 0 | 0 | 15 |
| pregnane X nuclear receptor | 8 | 0 | 0 | 8 |
| estrogen nuclear receptor alpha | 14 | 0 | 0 | 14 |
| cytochrome P450, family 19, subfamily A, polypeptide 1, isoform CRA_a | 10 | 0 | 0 | 10 |
| nuclear factor erythroid 2-related factor 2 isoform 2 | 6 | 0 | 0 | 6 |
| heat shock protein beta-1 | 2 | 0 | 0 | 2 |
| importin subunit beta-1 isoform 1 | 2 | 0 | 0 | 2 |
| snurportin-1 | 2 | 0 | 0 | 2 |
| tumor susceptibility gene 101 protein | 2 | 0 | 0 | 2 |
| GTP-binding nuclear protein Ran isoform 1 | 1 | 0 | 0 | 1 |
| Voltage-dependent calcium channel gamma-2 subunit | 8 | 0 | 0 | 8 |
| Cyclin-dependent kinase 1 | 0 | 1 | 0 | 1 |
| Heat shock protein HSP 90-beta | 0 | 1 | 0 | 1 |
| Glutamate receptor 2 | 9 | 0 | 0 | 9 |
| Xanthine dehydrogenase/oxidase | 0 | 3 | 0 | 3 |
| TAR DNA-binding protein 43 | 4 | 0 | 0 | 4 |
| Protein mono-ADP-ribosyltransferase PARP15 | 0 | 1 | 0 | 1 |
| Leucine-rich repeat serine/threonine-protein kinase 2 | 0 | 2 | 0 | 2 |
| ATPase family AAA domain-containing protein 5 | 7 | 0 | 0 | 7 |
| Ataxin-2 | 10 | 0 | 0 | 10 |
| interleukin 8 | 4 | 0 | 0 | 4 |
| estrogen receptor 2 (ER beta) | 6 | 0 | 0 | 6 |
| progesterone receptor | 7 | 0 | 0 | 7 |
| IDH1 | 6 | 0 | 0 | 6 |
| transcriptional regulator ERG isoform 3 | 2 | 0 | 0 | 2 |
| thyroid hormone receptor beta isoform 2 | 7 | 0 | 0 | 7 |
| ras-related protein Rab-9A | 3 | 0 | 0 | 3 |
| nuclear factor erythroid 2-related factor 2 isoform 1 | 9 | 0 | 0 | 9 |
| geminin | 11 | 0 | 0 | 11 |
| survival motor neuron protein isoform d | 6 | 0 | 0 | 6 |
| Polyphenol oxidase 2 | 0 | 1 | 0 | 1 |
| Hypoxanthine-guanine phosphoribosyltransferase | 0 | 0 | 0 | 1 |
| Cellular tumor antigen p53 | 10 | 0 | 0 | 10 |
| Xanthine dehydrogenase/oxidase [Includes: Xanthine dehydrogenase | 0 | 1 | 0 | 1 |
| Adenosine receptor A2a | 0 | 1 | 2 | 3 |
| Nuclear receptor ROR-gamma | 0 | 1 | 0 | 1 |
| Xanthine dehydrogenase/oxidase | 0 | 2 | 1 | 4 |
| Shiga toxin subunit A | 0 | 1 | 0 | 1 |
| Histamine H3 receptor | 0 | 1 | 0 | 1 |
| Carbonic anhydrase 1 | 0 | 6 | 0 | 10 |
| Carbonic anhydrase 2 | 0 | 7 | 0 | 10 |
| Neutral amino acid transporter A | 0 | 1 | 0 | 1 |
| Neutral amino acid transporter B(0) | 0 | 1 | 0 | 1 |
| Carbonic anhydrase-like protein, putative | 0 | 0 | 0 | 2 |
| Amino acid transporter | 0 | 1 | 0 | 1 |
| Chain A, TYROSYL-DNA PHOSPHODIESTERASE | 4 | 0 | 0 | 4 |
| Chain A, Phospholipase A2 isoform 3 | 0 | 0 | 1 | 1 |
| Chain A, 2-oxoglutarate Oxygenase | 2 | 0 | 0 | 2 |
| GTP-binding protein (rab7) | 0 | 0 | 1 | 1 |
| ras protein, partial | 0 | 0 | 1 | 1 |
| hypothetical protein, conserved | 1 | 0 | 0 | 1 |
| retinoic acid nuclear receptor alpha variant 1 | 12 | 0 | 0 | 12 |
| cytochrome P450 2D6 | 3 | 0 | 0 | 3 |
| glucocerebrosidase | 2 | 0 | 0 | 2 |
| peroxisome proliferator-activated receptor delta | 5 | 0 | 0 | 5 |
| Rac1 protein | 0 | 0 | 1 | 1 |
| cell division cycle 42 (GTP binding protein, 25kDa), partial | 0 | 0 | 1 | 1 |
| DNA polymerase kappa isoform 1 | 2 | 0 | 0 | 2 |
| muscarinic acetylcholine receptor M1 | 3 | 0 | 0 | 3 |
| lethal factor (plasmid) | 2 | 0 | 0 | 2 |
| Prostaglandin-H2 D-isomerase | 0 | 1 | 0 | 1 |
| Prostaglandin G/H synthase 1 | 0 | 1 | 0 | 1 |
| Prostaglandin G/H synthase 2 | 0 | 1 | 0 | 1 |
| Epidermal growth factor receptor | 0 | 1 | 0 | 1 |
| Fatty acid-binding protein, liver | 0 | 2 | 0 | 2 |
| Integrin beta-3 | 0 | 1 | 0 | 1 |
| Myeloperoxidase | 0 | 1 | 0 | 1 |
| Prostaglandin G/H synthase 1 | 0 | 1 | 0 | 1 |
| Seed linoleate 13S-lipoxygenase-1 | 0 | 1 | 0 | 1 |
| Integrin alpha-IIb | 0 | 1 | 0 | 1 |
| Glutathione hydrolase 1 proenzyme | 0 | 1 | 0 | 1 |
| Prostaglandin G/H synthase 1 | 0 | 2 | 0 | 2 |
| Adenosine receptor A1 | 0 | 1 | 0 | 2 |
| Adenosine receptor A2a | 0 | 1 | 0 | 2 |
| Substance-P receptor | 0 | 1 | 0 | 1 |
| Prostaglandin G/H synthase 2 | 0 | 3 | 0 | 3 |
| Urotensin-2 receptor | 0 | 1 | 0 | 1 |
| 4-aminobutyrate aminotransferase, mitochondrial | 0 | 1 | 0 | 1 |
| Nuclear receptor ROR-gamma | 6 | 0 | 0 | 6 |
| Ras-related protein Rab-2A | 0 | 0 | 1 | 1 |
| Gamma-aminobutyric acid receptor subunit alpha-1 | 6 | 3 | 1 | 10 |
| Prostaglandin G/H synthase 2 | 0 | 1 | 0 | 1 |
| Rho-associated protein kinase 2 | 0 | 1 | 0 | 1 |
| Nicotinate phosphoribosyltransferase | 0 | 1 | 0 | 1 |
| Solute carrier family 22 member 20 | 0 | 1 | 0 | 1 |
| Solute carrier family 22 member 6 | 0 | 1 | 0 | 1 |
| Sigma non-opioid intracellular receptor 1 | 0 | 2 | 1 | 3 |
| Sigma non-opioid intracellular receptor 1 | 0 | 0 | 1 | 1 |
| Chain H, Proteasome component PUP1 | 0 | 1 | 0 | 1 |
| Chain I, Proteasome component PUP3 | 0 | 1 | 0 | 1 |
| Chain K, Proteasome component PRE2 | 0 | 1 | 0 | 1 |
| Chain L, Proteasome component C5 | 0 | 1 | 0 | 1 |
| Chain K, Proteasome component PRE2 | 0 | 1 | 0 | 1 |
| Chain L, Proteasome component C5 | 0 | 1 | 0 | 1 |
| Proteasome subunit beta type-11 | 0 | 1 | 0 | 1 |
| Fumarate hydratase | 4 | 0 | 0 | 4 |
| PPM1D protein | 3 | 0 | 0 | 3 |
| caspase 7, apoptosis-related cysteine protease | 3 | 0 | 0 | 3 |
| retinoid X nuclear receptor alpha | 5 | 0 | 0 | 5 |
| farnesoid X nuclear receptor | 6 | 0 | 0 | 6 |
| polyprotein | 4 | 0 | 0 | 4 |
| peroxisome proliferator activated receptor gamma | 6 | 0 | 0 | 6 |
| vitamin D (1,25- dihydroxyvitamin D3) receptor | 7 | 0 | 0 | 7 |
| caspase-3 | 3 | 0 | 0 | 3 |
| nuclear receptor subfamily 1, group I, member 2 | 2 | 0 | 0 | 2 |
| Caspase-7 | 3 | 0 | 0 | 3 |
| caspase-3 | 3 | 0 | 0 | 3 |
| 26S proteasome non-ATPase regulatory subunit 11 | 0 | 1 | 0 | 1 |
| 26S proteasome non-ATPase regulatory subunit 12 | 0 | 1 | 0 | 1 |
| 26S proteasome non-ATPase regulatory subunit 14 | 0 | 1 | 0 | 1 |
| Proteasome subunit alpha type-7 | 0 | 1 | 0 | 1 |
| Histone deacetylase 3 | 0 | 3 | 0 | 3 |
| 26S proteasome non-ATPase regulatory subunit 3 | 0 | 1 | 0 | 1 |
| Carbonic anhydrase 12 | 0 | 1 | 0 | 2 |
| Prothrombin | 0 | 1 | 0 | 1 |
| Chymotrypsinogen A | 0 | 1 | 0 | 1 |
| Interferon beta | 9 | 0 | 0 | 9 |
| Carbonic anhydrase 3 | 0 | 1 | 0 | 2 |
| Cathepsin B | 0 | 1 | 0 | 1 |
| Neutrophil elastase | 0 | 1 | 0 | 1 |
| Cathepsin G | 0 | 2 | 0 | 2 |
| Lysosomal protective protein | 0 | 1 | 0 | 1 |
| Chymotrypsinogen B | 0 | 1 | 0 | 1 |
| 26S proteasome regulatory subunit 6A | 0 | 1 | 0 | 1 |
| Nuclear factor NF-kappa-B p105 subunit | 0 | 1 | 0 | 1 |
| Proteasome subunit beta type-1 | 0 | 1 | 0 | 2 |
| Carbonic anhydrase 4 | 0 | 3 | 0 | 4 |
| Carbonic anhydrase 6 | 0 | 1 | 0 | 2 |
| Chymase | 0 | 1 | 0 | 1 |
| Proteasome subunit alpha type-1 | 0 | 1 | 0 | 1 |
| Proteasome subunit alpha type-2 | 0 | 1 | 0 | 1 |
| Proteasome subunit alpha type-3 | 0 | 1 | 0 | 1 |
| Proteasome subunit alpha type-4 | 0 | 1 | 0 | 1 |
| Proteasome subunit beta type-8 | 0 | 1 | 0 | 1 |
| Proteasome subunit beta type-8 | 0 | 1 | 0 | 1 |
| Proteasome subunit beta type-9 | 0 | 1 | 0 | 1 |
| Proteasome subunit alpha type-5 | 0 | 1 | 0 | 1 |
| Proteasome subunit beta type-4 | 0 | 1 | 0 | 1 |
| Proteasome subunit beta type-6 | 0 | 1 | 0 | 1 |
| Proteasome subunit beta type-5 | 0 | 2 | 0 | 3 |
| Carbonic anhydrase 5A, mitochondrial | 0 | 3 | 0 | 4 |
| 26S proteasome regulatory subunit 7 | 0 | 1 | 0 | 1 |
| Lon protease homolog, mitochondrial | 0 | 1 | 0 | 1 |
| Proteasome subunit beta type-10 | 0 | 1 | 0 | 1 |
| Carbonic anhydrase 7 | 0 | 1 | 0 | 2 |
| 26S proteasome regulatory subunit 6B | 0 | 1 | 0 | 1 |
| 26S proteasome non-ATPase regulatory subunit 8 | 0 | 1 | 0 | 1 |
| Proteasome subunit beta type-3 | 0 | 1 | 0 | 1 |
| Proteasome subunit beta type-2 | 0 | 1 | 0 | 2 |
| 26S proteasome non-ATPase regulatory subunit 7 | 0 | 1 | 0 | 1 |
| 26S proteasome non-ATPase regulatory subunit 4 | 0 | 1 | 0 | 1 |
| 26S proteasome complex subunit SEM1 | 0 | 1 | 0 | 1 |
| Proteasome subunit alpha type-6 | 0 | 1 | 0 | 1 |
| 26S proteasome regulatory subunit 4 | 0 | 1 | 0 | 1 |
| 26S proteasome regulatory subunit 8 | 0 | 1 | 0 | 1 |
| 26S proteasome regulatory subunit 10B | 0 | 1 | 0 | 1 |
| Beta-carbonic anhydrase 1 | 0 | 1 | 0 | 1 |
| Nuclear factor NF-kappa-B p100 subunit | 0 | 1 | 0 | 1 |
| Transcription factor p65 | 0 | 1 | 0 | 1 |
| 26S proteasome non-ATPase regulatory subunit 2 | 0 | 1 | 0 | 1 |
| Histone deacetylase 1 | 0 | 3 | 0 | 3 |
| 26S proteasome non-ATPase regulatory subunit 6 | 0 | 1 | 0 | 1 |
| Proteasomal ubiquitin receptor ADRM1 | 0 | 1 | 0 | 1 |
| Carbonic anhydrase 9 | 0 | 3 | 0 | 4 |
| ATP-dependent Clp protease proteolytic subunit | 0 | 1 | 1 | 2 |
| Carbonic anhydrase 13 | 0 | 1 | 0 | 2 |
| NACHT, LRR and PYD domains-containing protein 3 | 0 | 1 | 0 | 1 |
| Proteasome subunit alpha-type 8 | 0 | 1 | 0 | 1 |
| Histone deacetylase 2 | 0 | 3 | 0 | 3 |
| Proteasome subunit beta type-7 | 0 | 1 | 0 | 1 |
| 26S proteasome non-ATPase regulatory subunit 1 | 0 | 1 | 0 | 1 |
| Carbonic anhydrase 15 | 0 | 1 | 0 | 2 |
| Histone deacetylase 8 | 0 | 3 | 0 | 3 |
| Histone deacetylase 6 | 0 | 3 | 0 | 3 |
| Carbonic anhydrase 14 | 0 | 1 | 0 | 2 |
| 26S proteasome non-ATPase regulatory subunit 13 | 0 | 1 | 0 | 1 |
| Carbonic anhydrase 5B, mitochondrial | 0 | 1 | 0 | 2 |
| Chain A, Beta-lactamase | 2 | 0 | 0 | 2 |
| acetylcholinesterase | 2 | 0 | 0 | 2 |
| USP1 protein, partial | 7 | 0 | 0 | 7 |
| thyroid hormone receptor beta isoform a | 7 | 0 | 0 | 7 |
| mitogen-activated protein kinase 1 | 3 | 0 | 0 | 3 |
| Vpr | 1 | 0 | 0 | 1 |
| Albumin | 0 | 0 | 1 | 1 |
| Major prion protein | 0 | 0 | 1 | 1 |
| Sodium channel protein type 1 subunit alpha | 0 | 2 | 0 | 2 |
| Sodium channel protein type 2 subunit alpha | 0 | 3 | 0 | 3 |
| Sodium channel protein type 3 subunit alpha | 0 | 2 | 0 | 2 |
| UDP-glucuronosyltransferase 2B7 | 0 | 1 | 0 | 3 |
| Cytochrome P450 2B6 | 0 | 0 | 1 | 1 |
| Sodium channel protein type 4 subunit alpha | 0 | 3 | 0 | 5 |
| Potassium voltage-gated channel subfamily H member 2 | 0 | 5 | 0 | 5 |
| Sodium channel protein type 9 subunit alpha | 0 | 4 | 0 | 4 |
| Frizzled-8 | 0 | 0 | 1 | 1 |
| P2X purinoceptor 4 | 0 | 1 | 0 | 1 |
| glp-1 receptor, partial | 3 | 0 | 0 | 3 |
| pregnane X receptor | 3 | 0 | 0 | 3 |
| ATAD5 protein, partial | 4 | 0 | 0 | 4 |
| GLI family zinc finger 3 | 7 | 0 | 0 | 7 |
| 67.9K protein | 2 | 0 | 0 | 2 |
| P53 | 1 | 0 | 0 | 1 |
| RPL19A | 0 | 0 | 1 | 1 |
| aryl hydrocarbon receptor | 4 | 0 | 0 | 4 |
| v-jun sarcoma virus 17 oncogene homolog (avian) | 4 | 0 | 0 | 4 |
| Spike glycoprotein | 0 | 0 | 1 | 1 |
| Replicase polyprotein 1ab | 0 | 0 | 2 | 2 |
| NPC intracellular cholesterol transporter 1 precursor | 2 | 0 | 0 | 2 |
| cellular tumor antigen p53 isoform a | 1 | 0 | 0 | 1 |
| chromobox protein homolog 1 | 6 | 0 | 0 | 6 |
| nuclear factor NF-kappa-B p105 subunit isoform 1 | 1 | 0 | 0 | 1 |
| heat shock protein HSP 90-alpha isoform 2 | 0 | 0 | 0 | 1 |
| urokinase-type plasminogen activator precursor | 2 | 0 | 0 | 2 |
| plasminogen precursor | 2 | 0 | 0 | 2 |
| urokinase plasminogen activator surface receptor precursor | 2 | 0 | 0 | 2 |
| nuclear receptor ROR-gamma isoform 1 | 5 | 0 | 0 | 5 |
| transactivating tegument protein VP16 [Human herpesvirus 1] | 0 | 2 | 0 | 2 |
| cytochrome P450 3A4 isoform 1 | 6 | 0 | 0 | 6 |
| COUP transcription factor 2 isoform a | 0 | 1 | 0 | 1 |
| Gamma-aminobutyric acid receptor subunit pi | 6 | 2 | 1 | 9 |
| Transmembrane protease serine 2 | 0 | 0 | 1 | 1 |
| Glucose transporter | 0 | 1 | 0 | 1 |
| Hexose transporter 1 | 0 | 1 | 0 | 1 |
| Procathepsin L | 0 | 0 | 1 | 1 |
| Polyunsaturated fatty acid 5-lipoxygenase | 0 | 1 | 0 | 1 |
| Replicase polyprotein 1a | 0 | 0 | 1 | 1 |
| Replicase polyprotein 1ab | 0 | 0 | 1 | 1 |
| Replicase polyprotein 1ab | 0 | 0 | 1 | 1 |
| Replicase polyprotein 1ab | 0 | 0 | 1 | 1 |
| Solute carrier family 2, facilitated glucose transporter member 1 | 0 | 1 | 0 | 1 |
| Gamma-aminobutyric acid receptor subunit beta-1 | 6 | 2 | 1 | 9 |
| Gamma-aminobutyric acid receptor subunit delta | 6 | 2 | 1 | 9 |
| Gamma-aminobutyric acid receptor subunit gamma-2 | 6 | 2 | 1 | 9 |
| Gamma-aminobutyric acid receptor subunit alpha-5 | 6 | 2 | 1 | 9 |
| Gamma-aminobutyric acid receptor subunit alpha-3 | 6 | 2 | 1 | 9 |
| Gamma-aminobutyric acid receptor subunit gamma-1 | 6 | 2 | 1 | 9 |
| Gamma-aminobutyric acid receptor subunit alpha-2 | 6 | 2 | 1 | 9 |
| Gamma-aminobutyric acid receptor subunit alpha-4 | 6 | 2 | 1 | 9 |
| Gamma-aminobutyric acid receptor subunit gamma-3 | 6 | 2 | 1 | 9 |
| Gamma-aminobutyric acid receptor subunit alpha-6 | 6 | 2 | 1 | 9 |
| Alpha-synuclein | 1 | 0 | 0 | 1 |
| Spike glycoprotein | 2 | 0 | 1 | 3 |
| Eukaryotic initiation factor 4A-I | 0 | 1 | 0 | 1 |
| Peptidyl-prolyl cis-trans isomerase FKBP1A | 0 | 2 | 0 | 2 |
| Gamma-aminobutyric acid receptor subunit beta-3 | 6 | 2 | 1 | 9 |
| Gamma-aminobutyric acid receptor subunit beta-2 | 6 | 2 | 1 | 9 |
| Peptidyl-prolyl cis-trans isomerase FKBP3 | 0 | 1 | 0 | 1 |
| Peptidyl-prolyl cis-trans isomerase FKBP4 | 0 | 1 | 0 | 1 |
| Peptidyl-prolyl cis-trans isomerase NIMA-interacting 1 | 0 | 1 | 0 | 1 |
| Hypoxia-inducible factor 1-alpha | 0 | 1 | 0 | 1 |
| GABA theta subunit | 6 | 2 | 1 | 9 |
| Endothelial PAS domain-containing protein 1 | 0 | 1 | 0 | 1 |
| Angiotensin-converting enzyme 2 | 0 | 0 | 1 | 1 |
| Gamma-aminobutyric acid receptor subunit epsilon | 6 | 2 | 1 | 9 |
| Peptidyl-prolyl cis-trans isomerase FKBP14 | 0 | 1 | 0 | 1 |
| Peptidyl-prolyl cis-trans isomerase NIMA-interacting 4 | 0 | 1 | 0 | 1 |
| heat shock protein 90, putative | 0 | 0 | 0 | 1 |
| endonuclease IV | 4 | 0 | 0 | 4 |
| G | 4 | 0 | 0 | 4 |
| LMP1 [Human herpesvirus 4] | 0 | 0 | 0 | 2 |
| nuclear receptor coactivator 1 isoform 1 [Homo sapiens] | 0 | 1 | 0 | 1 |
| serine/threonine-protein kinase mTOR isoform 1 | 2 | 0 | 0 | 2 |
| peptidyl-prolyl cis-trans isomerase NIMA-interacting 1 | 2 | 0 | 0 | 2 |
| peripheral myelin protein 22 | 4 | 0 | 0 | 4 |
| nuclear receptor coactivator 3 isoform a | 0 | 1 | 0 | 1 |
| Thymidine kinase 2, mitochondrial | 0 | 1 | 0 | 1 |
| HLA class I histocompatibility antigen, B alpha chain | 4 | 0 | 0 | 4 |
| Thymidine kinase | 0 | 1 | 0 | 1 |
| Thymidylate synthase | 0 | 0 | 0 | 1 |
| Cytochrome P450 3A4 | 0 | 2 | 0 | 2 |
| Thymidine kinase | 0 | 1 | 0 | 1 |
| Deoxycytidine kinase | 0 | 0 | 0 | 1 |
| Probable deoxycytidylate deaminase | 0 | 0 | 0 | 1 |
| Cytidine deaminase | 0 | 1 | 0 | 2 |
| D(1A) dopamine receptor | 2 | 0 | 0 | 2 |
| E3 ubiquitin-protein ligase Mdm2 | 0 | 1 | 0 | 1 |
| Enoyl-[acyl-carrier-protein] reductase [NADH] | 0 | 1 | 0 | 1 |
| Inositol hexakisphosphate kinase 1 | 4 | 0 | 0 | 4 |
| Deoxynucleoside kinase | 0 | 1 | 0 | 1 |
| cytochrome P450 2C9, partial | 4 | 0 | 0 | 4 |
| ATP-dependent phosphofructokinase | 2 | 0 | 0 | 2 |
| Deoxycytidine kinase | 0 | 0 | 0 | 1 |
| Chain A, Putative fructose-1,6-bisphosphate aldolase | 2 | 0 | 0 | 2 |
| Chain A, Cruzipain | 1 | 0 | 0 | 1 |
| 15-lipoxygenase, partial | 2 | 0 | 0 | 2 |
| hypoxia-inducible factor 1 alpha subunit | 2 | 0 | 0 | 2 |
| hypoxia-inducible factor 1, alpha subunit (basic helix-loop-helix transcription factor) | 5 | 0 | 0 | 5 |
| RAD51 | 0 | 1 | 0 | 1 |
| vitamin D3 receptor isoform VDRA | 3 | 0 | 0 | 3 |
| huntingtin isoform 2 | 2 | 0 | 0 | 2 |
| histone-lysine N-methyltransferase 2A isoform 2 precursor | 2 | 0 | 0 | 2 |
| caspase-1 isoform alpha precursor | 1 | 0 | 0 | 1 |
| ATP-dependent translocase ABCB1 | 0 | 2 | 1 | 4 |
| Dolichyl-diphosphooligosaccharide--protein glycosyltransferase subunit 1 | 0 | 1 | 0 | 1 |
| Caspase-7 | 1 | 0 | 0 | 1 |
| Growth factor receptor-bound protein 2 | 0 | 1 | 0 | 1 |
| Pantothenate synthetase | 0 | 1 | 0 | 1 |
| Discoidin domain-containing receptor 2 | 0 | 1 | 0 | 1 |
| Growth factor receptor-bound protein 2 | 0 | 1 | 0 | 1 |
| Reverse transcriptase/RNaseH | 0 | 2 | 1 | 3 |
| Peptide-N(4)-(N-acetyl-beta-glucosaminyl)asparagine amidase | 0 | 0 | 1 | 1 |
| Chain A, probable fosfomycin resistance protein | 0 | 0 | 1 | 1 |
| Chain B, probable fosfomycin resistance protein | 0 | 0 | 1 | 1 |
| DNA polymerase catalytic subunit | 0 | 1 | 0 | 1 |
| DNA polymerase catalytic subunit | 0 | 1 | 0 | 1 |
| DNA polymerase alpha catalytic subunit | 0 | 1 | 0 | 1 |
| DNA polymerase delta catalytic subunit | 0 | 1 | 0 | 1 |
| ClpP | 1 | 0 | 0 | 1 |
| NFKB1 protein, partial | 1 | 0 | 0 | 1 |
| Transitional endoplasmic reticulum ATPase | 0 | 1 | 0 | 1 |
| Chain A, HISTIDINE-BINDING PROTEIN | 0 | 0 | 1 | 1 |
| Chain E, LYSINE, ARGININE, ORNITHINE-BINDING PROTEIN | 0 | 0 | 1 | 1 |
| Chain E, LYSINE, ARGININE, ORNITHINE-BINDING PROTEIN | 0 | 0 | 1 | 1 |
| Chain E, LYSINE, ARGININE, ORNITHINE-BINDING PROTEIN | 0 | 0 | 1 | 1 |
| histone acetyltransferase KAT2A isoform 1 | 2 | 0 | 0 | 2 |
| Plasma kallikrein | 0 | 0 | 0 | 1 |
| Histidine-binding periplasmic protein | 0 | 0 | 1 | 1 |
| 5-hydroxytryptamine receptor 1D | 0 | 0 | 0 | 1 |
| Glutamate receptor ionotropic, NMDA 1 | 0 | 0 | 0 | 1 |
| Carbonic anhydrase | 0 | 0 | 0 | 1 |
| Carbonic anhydrase | 0 | 0 | 0 | 1 |
| Glutamate receptor ionotropic, NMDA 2A | 0 | 0 | 0 | 1 |
| Glutamate receptor ionotropic, NMDA 2B | 0 | 0 | 0 | 1 |
| Glutamate receptor ionotropic, NMDA 2C | 0 | 0 | 0 | 1 |
| Large neutral amino acids transporter small subunit 1 | 0 | 1 | 0 | 1 |
| Glutaminyl-peptide cyclotransferase | 0 | 1 | 0 | 1 |
| Carbonic anhydrase | 0 | 0 | 0 | 1 |
| Carbonic anhydrase | 0 | 0 | 0 | 1 |
| Carbonic anhydrase | 0 | 0 | 0 | 1 |
| Glutamate receptor ionotropic, NMDA 2D | 0 | 0 | 0 | 1 |
| Carbonic anhydrase | 0 | 0 | 0 | 1 |
| Glutamate receptor ionotropic, NMDA 3B | 0 | 0 | 0 | 1 |
| Carbonic anhydrase 4 | 0 | 0 | 0 | 1 |
| Carbonic anhydrase 13 | 0 | 0 | 0 | 1 |
| Glutamate receptor ionotropic, NMDA 3A | 0 | 0 | 0 | 1 |
| DNA polymerase III, partial | 1 | 0 | 0 | 1 |
| regulator of G-protein signaling 4 | 2 | 0 | 0 | 2 |
| nonstructural protein 1 | 1 | 0 | 0 | 1 |
| NPYLR7B | 0 | 0 | 1 | 1 |
| Parkin | 1 | 0 | 0 | 1 |
| hexokinase-4 isoform 1 | 1 | 0 | 0 | 1 |
| peripheral myelin protein 22 isoform 1 | 2 | 0 | 0 | 2 |
| D(1A) dopamine receptor | 2 | 0 | 0 | 2 |
| potassium voltage-gated channel subfamily H member 2 isoform d | 3 | 0 | 0 | 3 |
| glucokinase regulatory protein | 1 | 0 | 0 | 1 |
| DNA polymerase beta | 1 | 0 | 0 | 1 |
| eyes absent homolog 2 isoform a | 1 | 0 | 0 | 1 |
| DNA polymerase eta isoform 1 | 1 | 0 | 0 | 1 |
| M-phase phosphoprotein 8 | 1 | 0 | 0 | 1 |
| muscleblind-like protein 1 isoform 1 | 1 | 0 | 0 | 1 |
| Amyloid-beta precursor protein | 1 | 0 | 0 | 1 |
| Glutamate receptor 1 | 1 | 0 | 0 | 1 |
| Glutamate receptor 3 | 1 | 0 | 0 | 1 |
| Glutamate receptor 4 | 1 | 0 | 0 | 1 |
| Inositol monophosphatase 1 | 2 | 0 | 0 | 2 |
| Single-stranded DNA cytosine deaminase | 1 | 0 | 0 | 1 |
| Potassium channel subfamily K member 3 | 0 | 1 | 0 | 1 |
| Potassium channel subfamily K member 2 | 0 | 1 | 0 | 1 |
| Potassium voltage-gated channel subfamily A member 5 | 0 | 1 | 0 | 1 |
| Sodium channel protein type 5 subunit alpha | 0 | 3 | 0 | 3 |
| Potassium voltage-gated channel subfamily D member 2 | 0 | 1 | 0 | 1 |
| Potassium channel subfamily K member 18 | 0 | 1 | 0 | 1 |
| Multidrug and toxin extrusion protein 1 | 0 | 1 | 0 | 1 |
| Sodium channel protein type 3 subunit alpha | 0 | 3 | 0 | 3 |
| thioredoxin glutathione reductase | 2 | 0 | 0 | 2 |
| Large neutral amino acids transporter small subunit 1 | 0 | 1 | 0 | 1 |
| Glutaminyl-peptide cyclotransferase | 0 | 1 | 0 | 1 |
| Sodium channel protein type 1 subunit alpha | 0 | 2 | 0 | 2 |
| Sodium channel protein type 2 subunit alpha | 0 | 2 | 0 | 2 |
| Gamma-aminobutyric acid | 0 | 1 | 0 | 1 |
| cytochrome P450 2C9 precursor | 2 | 0 | 0 | 2 |
| parathyroid hormone/parathyroid hormone-related peptide receptor precursor | 1 | 0 | 0 | 1 |
| Gamma-aminobutyric acid receptor subunit pi | 0 | 1 | 0 | 1 |
| Gamma-aminobutyric acid receptor subunit delta | 0 | 1 | 0 | 1 |
| Voltage-dependent L-type calcium channel subunit alpha-1C | 0 | 2 | 0 | 2 |
| Voltage-dependent L-type calcium channel subunit alpha-1F | 0 | 1 | 0 | 1 |
| Dihydrofolate reductase | 0 | 1 | 0 | 1 |
| Gamma-aminobutyric acid receptor subunit alpha-1 | 0 | 1 | 0 | 1 |
| Aldo-keto reductase family 1 member B1 | 0 | 1 | 0 | 1 |
| Gamma-aminobutyric acid receptor subunit alpha-6 | 0 | 1 | 0 | 1 |
| Gamma-aminobutyric acid receptor subunit beta-1 | 0 | 1 | 0 | 1 |
| Gamma-aminobutyric acid receptor subunit gamma-2 | 0 | 1 | 0 | 1 |
| 5-hydroxytryptamine receptor 1A | 0 | 3 | 1 | 5 |
| Gamma-aminobutyric acid receptor subunit gamma-2 | 0 | 1 | 0 | 1 |
| Gamma-aminobutyric acid receptor subunit delta | 0 | 1 | 0 | 1 |
| Gamma-aminobutyric acid receptor subunit alpha-2 | 0 | 1 | 0 | 1 |
| Gamma-aminobutyric acid receptor subunit alpha-3 | 0 | 1 | 0 | 1 |
| Gamma-aminobutyric acid receptor subunit gamma-3 | 0 | 1 | 0 | 1 |
| Gamma-aminobutyric acid receptor subunit beta-3 | 0 | 1 | 0 | 1 |
| Gamma-aminobutyric acid receptor subunit alpha-5 | 0 | 1 | 0 | 1 |
| Gamma-aminobutyric acid receptor subunit alpha-3 | 0 | 1 | 0 | 1 |
| Histamine H2 receptor | 2 | 0 | 0 | 2 |
| Gamma-aminobutyric acid receptor subunit alpha-2 | 0 | 1 | 0 | 1 |
| Gamma-aminobutyric acid receptor subunit beta-2 | 0 | 1 | 0 | 1 |
| Gamma-aminobutyric acid receptor subunit alpha-4 | 0 | 1 | 0 | 1 |
| Gamma-aminobutyric acid receptor subunit beta-1 | 0 | 1 | 0 | 1 |
| Gamma-aminobutyric acid receptor subunit alpha-1 | 0 | 1 | 0 | 1 |
| Gamma-aminobutyric acid receptor subunit beta-3 | 0 | 1 | 0 | 1 |
| Gamma-aminobutyric acid receptor subunit epsilon | 0 | 1 | 0 | 1 |
| Voltage-dependent L-type calcium channel subunit alpha-1D | 0 | 1 | 0 | 1 |
| Voltage-dependent L-type calcium channel subunit alpha-1S | 0 | 1 | 0 | 1 |
| Voltage-dependent L-type calcium channel subunit alpha-1C | 0 | 2 | 0 | 2 |
| Gamma-aminobutyric acid receptor subunit alpha-6 | 0 | 1 | 0 | 1 |
| Gamma-aminobutyric acid receptor subunit alpha-5 | 0 | 1 | 0 | 1 |
| Gamma-aminobutyric acid receptor subunit gamma-1 | 0 | 1 | 0 | 1 |
| Gamma-aminobutyric acid receptor subunit pi | 0 | 1 | 0 | 1 |
| Gamma-aminobutyric acid receptor subunit gamma-3 | 0 | 1 | 0 | 1 |
| Gamma-aminobutyric acid receptor subunit alpha-4 | 0 | 1 | 0 | 1 |
| Gamma-aminobutyric acid receptor subunit theta | 0 | 1 | 0 | 1 |
| Gamma-aminobutyric acid receptor subunit gamma-1 | 0 | 1 | 0 | 1 |
| Gamma-aminobutyric acid receptor subunit theta | 0 | 1 | 0 | 1 |
| luciferase | 0 | 0 | 0 | 1 |
| Estrogen receptor | 0 | 2 | 0 | 2 |
| Glucocorticoid receptor | 0 | 4 | 2 | 11 |
| Progesterone receptor | 0 | 2 | 0 | 3 |
| Glucocorticoid receptor | 0 | 1 | 1 | 2 |
| Glucocorticoid receptor | 0 | 0 | 1 | 1 |
| Glycine receptor subunit alpha-1 | 0 | 4 | 0 | 4 |
| Corticosteroid-binding globulin | 0 | 1 | 0 | 1 |
| Mineralocorticoid receptor | 0 | 2 | 1 | 3 |
| Androgen receptor | 0 | 2 | 0 | 2 |
| Glutamine synthetase | 0 | 0 | 1 | 1 |
| Androgen receptor | 0 | 3 | 0 | 3 |
| Glycine receptor subunit beta | 0 | 4 | 0 | 4 |
| Glycine receptor subunit alpha-2 | 0 | 4 | 0 | 4 |
| Glycine receptor subunit alpha-3 | 0 | 4 | 0 | 4 |
| Histamine H1 receptor | 0 | 0 | 1 | 1 |
| Nociceptin receptor | 0 | 0 | 1 | 1 |
| Estrogen receptor beta | 0 | 2 | 0 | 2 |
| Beta-1 adrenergic receptor | 0 | 1 | 1 | 3 |
| 5-hydroxytryptamine receptor 4 | 0 | 2 | 0 | 2 |
| Albumin | 0 | 0 | 1 | 1 |
| Cytochrome P450 1A2 | 0 | 1 | 0 | 1 |
| Beta-2 adrenergic receptor | 0 | 2 | 1 | 3 |
| Muscarinic acetylcholine receptor M2 | 0 | 1 | 1 | 2 |
| Beta-1 adrenergic receptor | 0 | 2 | 1 | 3 |
| 5-hydroxytryptamine receptor 1A | 0 | 1 | 0 | 1 |
| Alpha-2A adrenergic receptor | 0 | 1 | 2 | 4 |
| Adenosine receptor A3 | 0 | 1 | 1 | 2 |
| Beta-2 adrenergic receptor | 0 | 2 | 0 | 3 |
| Cytochrome P450 2C8 | 0 | 1 | 0 | 1 |
| Cytochrome P450 2D6 | 0 | 1 | 0 | 1 |
| Muscarinic acetylcholine receptor M1 | 0 | 1 | 1 | 2 |
| Beta-3 adrenergic receptor | 0 | 2 | 1 | 3 |
| D(2) dopamine receptor | 0 | 1 | 1 | 2 |
| Alpha-1B adrenergic receptor | 0 | 1 | 1 | 2 |
| Alpha-2B adrenergic receptor | 0 | 0 | 1 | 2 |
| Beta-1 adrenergic receptor | 0 | 2 | 1 | 4 |
| Alpha-2C adrenergic receptor | 0 | 1 | 2 | 4 |
| D(3) dopamine receptor | 0 | 1 | 0 | 1 |
| Alpha-2B adrenergic receptor | 0 | 0 | 1 | 1 |
| Muscarinic acetylcholine receptor M3 | 0 | 1 | 1 | 2 |
| D(1A) dopamine receptor | 0 | 1 | 1 | 2 |
| Voltage-dependent L-type calcium channel subunit alpha-1C | 0 | 1 | 0 | 1 |
| Alpha-2C adrenergic receptor | 0 | 0 | 1 | 1 |
| Alpha-2A adrenergic receptor | 0 | 0 | 1 | 1 |
| Alpha-1D adrenergic receptor | 0 | 1 | 1 | 2 |
| Alpha-1D adrenergic receptor | 0 | 0 | 1 | 2 |
| Endothelin-1 receptor | 0 | 1 | 1 | 2 |
| Beta-3 adrenergic receptor | 0 | 2 | 0 | 2 |
| 5-hydroxytryptamine receptor 1B | 0 | 2 | 1 | 3 |
| 5-hydroxytryptamine receptor 2A | 0 | 2 | 1 | 3 |
| 5-hydroxytryptamine receptor 2C | 0 | 2 | 1 | 3 |
| 5-hydroxytryptamine receptor 1B | 0 | 2 | 0 | 2 |
| Neuromedin-K receptor | 0 | 0 | 1 | 1 |
| Type-1 angiotensin II receptor | 0 | 1 | 1 | 2 |
| Sodium-dependent serotonin transporter | 0 | 2 | 0 | 2 |
| Cholecystokinin receptor type A | 0 | 1 | 1 | 2 |
| Cytochrome P450 2C19 | 0 | 1 | 0 | 1 |
| 5-hydroxytryptamine receptor 7 | 0 | 1 | 1 | 2 |
| Beta-1 adrenergic receptor | 0 | 1 | 0 | 1 |
| Alpha-1A adrenergic receptor | 0 | 1 | 2 | 4 |
| Alpha-1B adrenergic receptor | 0 | 0 | 1 | 2 |
| Mu-type opioid receptor | 0 | 1 | 1 | 2 |
| Vasopressin V1a receptor | 0 | 1 | 1 | 2 |
| Delta-type opioid receptor | 0 | 1 | 1 | 2 |
| Kappa-type opioid receptor | 0 | 1 | 1 | 2 |
| 5-hydroxytryptamine receptor 2B | 0 | 2 | 1 | 3 |
| Alpha-1A adrenergic receptor | 0 | 1 | 1 | 2 |
| 5-hydroxytryptamine receptor 6 | 0 | 2 | 1 | 3 |
| 5-hydroxytryptamine receptor 7 | 0 | 1 | 0 | 1 |
| Beta-2 adrenergic receptor | 0 | 1 | 0 | 1 |
| Sodium/bile acid cotransporter | 0 | 2 | 0 | 2 |
| Beta-2 adrenergic receptor | 0 | 1 | 1 | 3 |
| Nuclear receptor subfamily 2 group E member 1 | 0 | 0 | 2 | 2 |
| Chain A, Glutathione S-transferase | 0 | 1 | 0 | 1 |
| Luciferase | 2 | 0 | 0 | 2 |
| thyroid stimulating hormone receptor | 1 | 0 | 0 | 1 |
| histone deacetylase 9 isoform 3 | 1 | 0 | 0 | 1 |
| Solute carrier organic anion transporter family member 2B1 | 0 | 2 | 0 | 2 |
| Tumor necrosis factor | 0 | 0 | 1 | 1 |
| Interstitial collagenase | 0 | 1 | 0 | 1 |
| Fibroblast growth factor 1 | 0 | 0 | 1 | 1 |
| Thromboxane-A synthase | 0 | 1 | 0 | 1 |
| Mitogen-activated protein kinase 1 | 0 | 1 | 0 | 1 |
| Caspase-1 | 0 | 1 | 0 | 1 |
| Flavin reductase (NADPH) | 0 | 0 | 1 | 1 |
| Bifunctional purine biosynthesis protein ATIC | 0 | 1 | 0 | 1 |
| Solute carrier organic anion transporter family member 1B3 | 0 | 2 | 0 | 2 |
| Broad substrate specificity ATP-binding cassette transporter ABCG2 | 0 | 1 | 0 | 1 |
| Cystine/glutamate transporter | 0 | 1 | 0 | 1 |
| Solute carrier organic anion transporter family member 1B1 | 0 | 2 | 0 | 2 |
| Cocaine esterase | 0 | 1 | 0 | 1 |
| UDP-glucuronosyltransferase 1A9 | 0 | 0 | 0 | 1 |
| Aldo-keto reductase family 1 member B1 | 0 | 1 | 0 | 1 |
| Cytochrome P450 2A6 | 0 | 1 | 0 | 1 |
| Tissue factor | 0 | 1 | 0 | 1 |
| Aldo-keto reductase family 1 member A1 | 0 | 1 | 0 | 1 |
| UDP-glucuronosyltransferase 1-6 | 0 | 0 | 0 | 1 |
| Liver carboxylesterase 1 | 0 | 1 | 0 | 1 |
| Aldo-keto reductase family 1 member A1 | 0 | 1 | 0 | 1 |
| Histone deacetylase 4 | 0 | 2 | 0 | 2 |
| Aldo-keto reductase family 1 member A1 | 0 | 1 | 0 | 1 |
| Aldo-keto reductase family 1 member B7 | 0 | 1 | 0 | 1 |
| Sigma non-opioid intracellular receptor 1 | 0 | 1 | 0 | 1 |
| Histone deacetylase 7 | 0 | 2 | 0 | 2 |
| Polyamine deacetylase HDAC10 | 0 | 2 | 0 | 2 |
| Histone deacetylase 11 | 0 | 2 | 0 | 2 |
| NAD-dependent protein deacylase sirtuin-5, mitochondrial | 0 | 1 | 0 | 1 |
| Histone deacetylase 9 | 0 | 2 | 0 | 2 |
| Histone deacetylase 5 | 0 | 2 | 0 | 2 |
| [prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023] |